Scholar Rock Holding Corporation Share Price
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.30 USD | -5.07% |
|
-10.62% | +9.65% |
| 20/07 | Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026 | RE |
| 07/07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Market Cap | 578.77Cr 507.12Cr 470.78Cr 432.61Cr 815.18Cr 56TCr 827.18Cr 5.61TCr 2.2TCr 27TCr 2.17TCr 2.13TCr 94TCr | P/E 2026 * |
-15.2x | P/E 2027 * | -18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 548.56Cr 480.65Cr 446.21Cr 410.03Cr 772.64Cr 53TCr 784.01Cr 5.32TCr 2.08TCr 26TCr 2.06TCr 2.01TCr 89TCr | EV / Sales 2026 * |
842x | EV / Sales 2027 * | 36.3x |
| Free-Float |
99.22% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Scholar Rock Holding Corporation
| 1 day | -5.07% | ||
| 1 week | -10.62% | ||
| Current month | -12.18% | ||
| 1 month | -1.81% | ||
| 3 months | +2.05% | ||
| 6 months | +1.13% | ||
| Current year | +9.65% |
| 1 week | 47.28 |  | 53.33 |
| 1 month | 47.28 | | 58.49 |
| Current year | 38.75 | | 58.49 |
| 1 year | 27.07 | | 58.49 |
| 3 years | 5.93 | | 58.49 |
| 5 years | 4.32 | | 58.49 |
| 10 years | 4.32 | | 70 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Hallal
CEO | Chief Executive Officer | 59 | 27/04/2025 |
Vikas Sinha
DFI | Director of Finance/CFO | 62 | 27/04/2025 |
Robert Woods
COO | Chief Operating Officer | 58 | 27/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Hallal
CHM | Chairman | 59 | 01/07/2017 |
Kristina Burow
BRD | Director/Board Member | 53 | 01/08/2014 |
Jeffrey Flier
BRD | Director/Board Member | 78 | 01/10/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07/26 | ARCH Venture Partners LLC
| Other | Company | 0 | 0% | |
| 01/07/26 | Sell | Director | -3,053 | 0.0027% | ||
| 01/07/26 | Sell | Director | -2,544 | 0.0022% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.07% | -10.62% | +20.81% | +586.08% | 609.69Cr | |
| -0.43% | -4.26% | +52.09% | +85.69% | 5.56TCr | |
| -0.24% | +1.04% | +55.76% | +54.21% | 5.43TCr | |
| -1.82% | -2.89% | +3.61% | +405.88% | 2.35TCr | |
| -0.54% | -0.17% | -17.60% | -15.43% | 2.33TCr | |
| +0.31% | -0.92% | +35.51% | -3.92% | 2.03TCr | |
| +3.16% | +0.79% | +37.98% | -31.36% | 1.74TCr | |
| +0.58% | -0.48% | +38.67% | +551.63% | 1.56TCr | |
| +0.43% | -10.61% | +175.63% | +299.61% | 1.5TCr | |
| -2.03% | -1.03% | +23.63% | +179.23% | 1.41TCr | |
| Average | -0.57% | -1.70% | +42.61% | +211.16% | 2.45TCr | |
| Weighted average by Cap. | -0.31% | -0.70% | +43.51% | +144.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 65.12L 57.06L 52.97L 48.67L 91.72L 63Cr 93.07L 6.31Cr 2.47Cr 31Cr 2.44Cr 2.39Cr 106.21Cr | 15Cr 13Cr 12Cr 11Cr 21Cr 1.44TCr 21Cr 144.84Cr 57Cr 705.73Cr 56Cr 55Cr 2.44TCr |
| Net income | -41Cr -36Cr -33Cr -31Cr -58Cr -3.95TCr -59Cr -397Cr -155.38Cr -1.93TCr -153.8Cr -150.48Cr -6.68TCr | -36Cr -31Cr -29Cr -27Cr -50Cr -3.44TCr -51Cr -345.26Cr -135.13Cr -1.68TCr -133.75Cr -130.87Cr -5.81TCr |
| Net Debt | -30Cr -26Cr -25Cr -23Cr -43Cr -2.91TCr -43Cr -292.7Cr -114.56Cr -1.43TCr -113.39Cr -110.95Cr -4.93TCr | -36Cr -31Cr -29Cr -27Cr -50Cr -3.43TCr -51Cr -344.56Cr -134.86Cr -1.68TCr -133.48Cr -130.6Cr -5.8TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | $48.30 | -5.07% | 16,08,162 |
| 21/26/21 | $50.88 | +0.43% | 8,24,450 |
| 20/26/20 | $50.66 | -4.16% | 8,98,227 |
| 17/26/17 | $52.86 | +2.18% | 8,11,945 |
| 16/26/16 | $51.73 | -4.27% | 10,52,481 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SRRK Stock
Select your edition
All financial news and data tailored to specific country editions
